AdaptHealth Corp. (NASDAQ: AHCO) had its price target lowered by analysts at Royal Bank of Canada from $13.00 to $11.00. They now have an "outperform" rating on the stock.
AdaptHealth Corp. (NASDAQ: AHCO) had its price target lowered by analysts at Truist Financial Co. from $13.00 to $12.00. They now have a "buy" rating on the stock.
AdaptHealth Corp. to Participate in the Stifel 2024 Healthcare Conference
AdaptHealth Corp. (NASDAQ: AHCO) had its price target lowered by analysts at UBS Group AG from $13.00 to $12.00. They now have a "buy" rating on the stock.
AdaptHealth Corp. (NASDAQ: AHCO) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $14.00 to $13.00. They now have a "buy" rating on the stock.